The Pathogenetic Dilemma of Post-COVID-19 Mucormycosis in India-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Pathogenetic Dilemma of Post-COVID-19 Mucormycosis in India

Published:2022 Issue:1 Volume:13 Page:24
ISSN:2152-5250
Container-title:Aging and disease
language:en
Short-container-title:Aging and disease

Author:

Chakrabarti Sankha Shubhra,Kaur Upinder,Aggarwal Sushil Kumar,Kanakan Ahalya,Saini Adesh,Agrawal Bimal Kumar,Jin Kunlin,Chakrabarti Sasanka

Publisher

Aging and Disease

Subject

Cell Biology,Neurology (clinical),Geriatrics and Gerontology,Pathology and Forensic Medicine

Link

http://www.aginganddisease.org/fileup/2152-5250/PDF/ad-0-0-0-2108122242-1.pdf

Reference41 articles.

1. Liang KP, Tleyjeh IM, Wilson WR, Roberts GD, Temesgen Z (2006). Rhino-Orbitocerebral Mucormycosis Caused by Apophysomyces elegans. J Clin Microbiol, 44:892-898.

2. Prakash H, Chakrabarti A (2021). Epidemiology of Mucormycosis in India. Microorganisms, 9:523.

3. Raut A, Huy NT (2021). Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave? Lancet Respir Med, 9:e77.

4. Rammaert B, Lanternier F, Poirée S, Kania R, Lortholary O (2012). Diabetes and mucormycosis: A complex interplay. Diabetes Metab, 38:193-204.

5. Yang L, Gou J, Gao J, Huang L, Zhu Z, Ji S, et al. (2020). Immune characteristics of severe and critical COVID-19 patients. Signal Transduct Target Ther, 5:179.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19-Associated Rhinocerebral Mucormycosis, an Incidental Finding or a Matter of Concern – Mixed-Method Systematic Review;Infection and Drug Resistance;2024-01

2. Frequency and survival of Covid associated mucormycosis patients at tertiary care hospitals in Pakistan: A retrospective observational study;Health Science Reports;2023-02

3. Mucormycosis in the COVID-19 scenario beyond hospitalized patients;Future Microbiology;2023-01

4. Defective antifungal immunity in patients with COVID-19;Frontiers in Immunology;2022-11-30

5. Pathogenesis and Pathology of COVID-Associated Mucormycosis: What Is New and Why;Current Fungal Infection Reports;2022-09-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3